New Model Could Result in More Customized Bladder Cancer Treatments
Researchers from the Uppsala University have developed a new mouse model that can be used to study the factors that contribute to the progression of immune-system activation and bladder cancer in humans as the tumor grows. Through this model, the researchers have learned how proteins change prior to, during and after tumor development in the bladder wall. Their findings were published in the “PLOS ONE” journal. The study’s principal investigator Sara Mangsbo stated that the model was designed to demonstrate the harmful mutations observed in bladder cancer patients and to contain mutations that drive tumor growth, known as specific oncogenes.…
